Lewandowski M, Busch R, Marschner J, Merk D
ACS Pharmacol Transl Sci. 2025; .
PMID: 40046426
PMC: 7617459.
DOI: 10.1021/acsptsci.4c00719.
Saunders H, Holloran S, Trinca G, Artigues A, Villar M, Tinoco J
J Biol Chem. 2024; 300(11):107886.
PMID: 39395796
PMC: 11609360.
DOI: 10.1016/j.jbc.2024.107886.
Rao M, McDuffie E, Srivastava S, Plaisted W, Sachs C
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065726
PMC: 11279859.
DOI: 10.3390/ph17070875.
Burris T, de Vera I, Cote I, Flaveny C, Wanninayake U, Chatterjee A
Pharmacol Rev. 2023; 75(6):1233-1318.
PMID: 37586884
PMC: 10595025.
DOI: 10.1124/pharmrev.121.000436.
Shi Y, Kim H, Hamann C, Rhea E, Brunger J, Lippmann E
Fluids Barriers CNS. 2022; 19(1):77.
PMID: 36131285
PMC: 9494897.
DOI: 10.1186/s12987-022-00375-3.
Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs.
Li F, Song C, Zhang Y, Wu D
Acta Biochim Biophys Sin (Shanghai). 2022; 54(1):12-24.
PMID: 35130630
PMC: 9909358.
DOI: 10.3724/abbs.2021001.
The Role of Progesterone Receptors in Breast Cancer.
Li Z, Wei H, Li S, Wu P, Mao X
Drug Des Devel Ther. 2022; 16:305-314.
PMID: 35115765
PMC: 8801368.
DOI: 10.2147/DDDT.S336643.
Non-coding RNA crosstalk with nuclear receptors in liver disease.
Wu J, Nagy L, Liangpunsakul S, Wang L
Biochim Biophys Acta Mol Basis Dis. 2021; 1867(5):166083.
PMID: 33497819
PMC: 7987766.
DOI: 10.1016/j.bbadis.2021.166083.
Building a Chemical Toolbox for Human Pregnane X Receptor Research: Discovery of Agonists, Inverse Agonists, and Antagonists Among Analogs Based on the Unique Chemical Scaffold of SPA70.
Li Y, Lin W, Wright W, Chai S, Wu J, Chen T
J Med Chem. 2021; 64(3):1733-1761.
PMID: 33497575
PMC: 7880548.
DOI: 10.1021/acs.jmedchem.0c02201.
Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
Jaladanki C, He Y, Zhao L, Maurer-Stroh S, Loo L, Song H
Arch Toxicol. 2020; 95(1):355-374.
PMID: 32909075
PMC: 7811525.
DOI: 10.1007/s00204-020-02897-x.
Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.
Rani A, Stebbing J, Giamas G, Murphy J
Front Endocrinol (Lausanne). 2019; 10:245.
PMID: 31178825
PMC: 6543000.
DOI: 10.3389/fendo.2019.00245.
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR/HER2 Breast Cancer.
Guo Z, Tada H, Kitamura N, Hamada Y, Miyashita M, Harada-Shoji N
Cancers (Basel). 2019; 11(4).
PMID: 31013810
PMC: 6520781.
DOI: 10.3390/cancers11040526.
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.
Nardone A, Weir H, Delpuech O, Brown H, De Angelis C, Cataldo M
Br J Cancer. 2018; 120(3):331-339.
PMID: 30555156
PMC: 6353941.
DOI: 10.1038/s41416-018-0354-9.
The nuclear receptor superfamily: A structural perspective.
Weikum E, Liu X, Ortlund E
Protein Sci. 2018; 27(11):1876-1892.
PMID: 30109749
PMC: 6201731.
DOI: 10.1002/pro.3496.
Ginkgetin induces cell death in breast cancer cells via downregulation of the estrogen receptor.
Park Y, Woo S, Seo S, Kim H, Noh W, Lee J
Oncol Lett. 2017; 14(4):5027-5033.
PMID: 29085516
PMC: 5649541.
DOI: 10.3892/ol.2017.6742.
Allosteric pathways in nuclear receptors - Potential targets for drug design.
Fernandez E
Pharmacol Ther. 2017; 183:152-159.
PMID: 29080700
PMC: 5817003.
DOI: 10.1016/j.pharmthera.2017.10.014.
Antiestrogens: structure-activity relationships and use in breast cancer treatment.
Traboulsi T, El Ezzy M, Gleason J, Mader S
J Mol Endocrinol. 2016; 58(1):R15-R31.
PMID: 27729460
PMC: 5148801.
DOI: 10.1530/JME-16-0024.
Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.
Lagarde N, Delahaye S, Zagury J, Montes M
J Cheminform. 2016; 8(1):43.
PMID: 27602059
PMC: 5011875.
DOI: 10.1186/s13321-016-0154-2.
In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ.
Gao D, Zhang Y, Yang F, Lin Y, Zhang Q, Xia Z
Pharmacogn Mag. 2016; 12(46):120-7.
PMID: 27076748
PMC: 4809166.
DOI: 10.4103/0973-1296.177909.
Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid.
Morrissy S, Sun H, Zhang J, Strom J, Chen Q
J Biochem Mol Toxicol. 2016; 30(6):309-16.
PMID: 26915917
PMC: 4969002.
DOI: 10.1002/jbt.21795.